| |
| Issue |
Title |
| |
| Online First |
Strategies for antiviral treatment of COVID-19 and post-COVID syndrome: a narrative review of evidence-based approaches and pharmacoeconomic considerations |
Abstract
PDF (Rus)
|
|
S. А. Zykina, А. К. Turizhanova, I. R. Salpagarov, D. А. Polyakova, А. А. Temiev, К. Goyal, К. R. Nigmatullina, F. I. Kolesova, А. D. Chotchaeva, А. R. Permyakova, D. D. Bogatinova, С. R. Abdullaeva, К. S. Kobtseva |
| |
| Online First |
Artificial intelligence in healthcare: historical development, terminology, concepts, and classifications |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, A. I. Lamotkin, I. A. Lamotkin |
| |
| Online First |
Methodology approach to developing criteria for selecting hemophilia drugs included in the High-Cost Nosology program |
Abstract
PDF (Rus)
|
|
A. G. Kharitonova, V. V. Omelyanovskiy, K. I. Matrenin, A. A. Kingshott |
| |
| Online First |
Assessing rationality of resource allocation in a psychiatric facility |
Abstract
PDF (Rus)
|
|
N. K. Alimov, A. T. Sharaeva, A. A. Zurdinova |
| |
| Online First |
Clinical and economic aspects of semaglutide use in the treatment of obesity |
Abstract
PDF (Rus)
|
|
A. L. Tibilova, D. D. Kozaeva, R. R. Aslakhanova, V. Z. Tedety, M. Z. Tazurkaeva, D. E. Gurtsieva, E. E. Kanteeva, M. S. Gabueva, V. I. Guatsaeva, A. M. Dzhigkaeva, A. A. Tsokova, A. S. Petukhova |
| |
| Vol 1, No 19 (2026) |
Pharmacoeconomic evaluation of contemporary treatment, prevention, and screening strategies for melanoma: a review of evidence and implications for the Russian healthcare system |
Abstract
PDF (Rus)
|
|
V. M. Polezhaeva, D. S. Beloglazova, E. S. Trunina, A. A. Grinina, A. M. Burmagina, D. N. Gamzova, Yu. M. Kirdyashkina, А. N. Novikov, A. A. Khudiyarov, L. Aydasheva, D. F. Vorobyev, D. R. Khayrutdinova |
| |
| Vol 1, No 19 (2026) |
Pharmacoeconomic and socioeconomic aspects of multiple sclerosis treatment in different countries |
Abstract
PDF (Rus)
|
|
S. S. Maslova |
| |
| Vol 1, No 19 (2026) |
Concepts aimed at improving pharmaceutical care for patients with socially significant diseases in Russia and worldwide |
Abstract
PDF (Rus)
|
|
Yu. Sh. Gushchina, A. Yu. Abramov |
| |
| Online First |
Incretin-based therapy under pricing pressure: clinico-economic perspectives and role of biosimilar glucagon-like peptide-1 receptor agonists |
Abstract
PDF (Rus)
|
|
S. A. Kosobutskaya, D. Kh. Ausheva, M. A. Amirova, M. V. Belaya, S. A. Startseva, A. A. Samokhina, Ya. A. Vasileva, S. A. Kochetkova, B. P. Tsomaev, G. M. Dzgoev, N. T. Kokaeva, M. I. Sidakova, A. T. Kasaeva |
| |
| Vol 18, No 4 (2025) |
Biosensors for measuring nitric oxide NO levels in biosubstrates: a systematic analysis |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, L. A. Mayorova, A. N. Gromov |
| |
| Vol 18, No 4 (2025) |
Artificial intelligence in dermatology: a comparative analysis of computer vision programs based on machine learning models |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, A. I. Lamotkin |
| |
| Vol 18, No 4 (2025) |
Therapeutic targets of disease-modifying therapy for secondary osteoarthritis (DMOADs): a systematic review |
Abstract
PDF (Rus)
|
|
O. A. Gromova, A. I. Zagrebneva, I. V. Sarvilina, O. A. Shavlovskaya, I. Yu. Torshin, E. N. Simonova |
| |
| Vol 18, No 3 (2025) |
Cost and clinical effectiveness of fixed-dose combination therapies in the treatment of glaucoma patients: a systematic review |
Abstract
PDF (Rus)
|
|
Sh. Z. Umarova, Z. R. Usmonova, N. M. Normatova, N. M. Sultanbayeva |
| |
| Vol 18, No 3 (2025) |
Artificial intelligence in oncology: global experience and future prospects |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, A. I. Lamotkin |
| |
| Vol 18, No 2 (2025) |
Current approaches to the treatment of vulvovaginal atrophy in women with gynecological and breast cancer |
Abstract
PDF (Rus)
|
|
O. S. Gridasova, A. G. Solopova, E. I. Rumyantseva, A. E. Ivanov, D. О. Utkin, J. Kh. Khizroeva |
| |
| Vol 18, No 2 (2025) |
IgA nephropathy: predicting the risks of progression |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, M. E. Mantsaeva |
| |
| Vol 18, No 1 (2025) |
Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova |
| |
| Vol 18, No 1 (2025) |
Trends in the industry of clinical trials |
Abstract
PDF (Rus)
|
|
S. S. Milovanov, V. V. Popov, N. V. Teplova |
| |
| Vol 18, No 1 (2025) |
The effectiveness of using artificial intelligence in clinical medicine |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, A. I. Lamotkin |
| |
| Vol 17, No 4 (2024) |
Biologically active supplements: safety, efficacy, market review |
Abstract
PDF (Rus)
|
|
A. M. Stepanova, А. N. Plutnitskiy, E. V. Gameeva |
| |
| Vol 17, No 3 (2024) |
Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury |
Abstract
PDF (Rus)
|
|
M. O. Magomedaliev, D. I. Korabelnikov |
| |
| Vol 17, No 3 (2024) |
Biologically active supplements overview: regulation, market trends, application, and health impact |
Abstract
PDF (Rus)
|
|
A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva |
| |
| Vol 17, No 3 (2024) |
Artificial intelligence: basic terms and concepts, the application in healthcare and clinical medicine |
Abstract
PDF (Rus)
|
|
A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin |
| |
| Vol 17, No 3 (2024) |
Review of open libraries for pharmacoeconomic analysis in R environment |
Abstract
PDF (Rus)
|
|
I. A. Lackman, R. I. Sladkov, V. M. Timiryanova |
| |
| Vol 17, No 3 (2024) |
Experience of using Beers criteria in clinical practice (according to Russian literature) |
Abstract
PDF (Rus)
|
|
M. S. Cherniaeva, M. A. Rozhkova, M. V. Kazakova, L. A. Egorova, O. M. Maslennikova, G. S. Lebedev, N. V. Lomakin, D. A. Sychev |
| |
| Vol 17, No 2 (2024) |
Cystatin C: diagnostic and prognostic value in acute kidney injury |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, M. O. Magomedaliev |
| |
| Vol 17, No 2 (2024) |
Artificial intelligence in healthcare and medicine: the history of key events, its significance for doctors, the level of development in different countries |
Abstract
PDF (Rus)
|
|
A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin, S. A. Livshitz, E. G. Perevalova |
| |
| Vol 17, No 2 (2024) |
Approaches to determining the cost of laboratory tests |
Abstract
PDF (Rus)
|
|
I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky |
| |
| Vol 17, No 1 (2024) |
Compounding pharmacy regulations: experience of the Latvian pharmaceutical market |
Abstract
PDF (Rus)
|
|
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich |
| |
| Vol 16, No 4 (2023) |
Legal particularities of AI technology usage in real-world data formation |
Abstract
PDF (Rus)
|
|
V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya |
| |
| Vol 16, No 4 (2023) |
Peculiarities of real-world data application for health technology assessment in Asian countries |
Abstract
PDF (Rus)
|
|
B. B. Kondratyeva, F. V. Gorkavenko, V. V. Omelyanovskiy |
| |
| Vol 16, No 4 (2023) |
DMOADs and DMARDs in the treatment of patients with joint and spine diseases |
Abstract
PDF (Rus)
PDF (Eng)
|
|
O. A. Shavlovskaya |
| |
| Vol 16, No 4 (2023) |
Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova |
| |
| Vol 16, No 3 (2023) |
The prospects for the use of vitamin B12 derivatives in pharmacology |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, L. A. Maiorova |
| |
| Vol 16, No 3 (2023) |
Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. N. Gromov |
| |
| Vol 16, No 3 (2023) |
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova |
| |
| Vol 16, No 2 (2023) |
Key principles of drug therapy in patients with chronic myeloid leukemia |
Abstract
PDF (Rus)
|
|
A. V. Zhuravlev, O. I. Knysh |
| |
| Vol 16, No 2 (2023) |
Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin |
| |
| Vol 16, No 2 (2023) |
Real-world data: principles of use in decision making and in health technology assessment |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva |
| |
| Vol 16, No 2 (2023) |
Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions |
Abstract
PDF (Rus)
|
|
D. V. Blinov, A. G. Solopova, E. E. Achkasov, A. Yu. Vlasina, S. A. Akavova, V. N. Galkin, D. A. Petrenko, G. К. Bykovshchenko |
| |
| Vol 16, No 2 (2023) |
From misconceptions to reasonable osteoarthritis patients therapy |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov |
| |
| Vol 16, No 2 (2023) |
New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma |
Abstract
PDF (Rus)
|
|
M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina |
| |
| Vol 16, No 1 (2023) |
Compounding pharmacy regulations: experience of the North American pharmaceutical market |
Abstract
PDF (Rus)
|
|
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich |
| |
| Vol 16, No 1 (2023) |
Modern biomarkers of acute kidney injury |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, M. O. Magomedaliev |
| |
| Vol 16, No 1 (2023) |
Non-invasive respiratory support in patients with severe community-acquired pneumonia |
Abstract
PDF (Rus)
|
|
S. V. Korotchenko, D. I. Korabelnikov |
| |
| Vol 16, No 1 (2023) |
Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin |
| |
| Vol 16, No 1 (2023) |
Prospects for using high-throughput sequencing methods to identify new biomarkers of response and resistance to antitumor therapy |
Abstract
PDF (Rus)
|
|
M. А. Sorokina, T. R. Grishina |
| |
| Vol 15, No 4 (2022) |
Possibilities of physical therapy and electrophysical modalities in the complex therapy of pneumonia |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, V. V. Grigoryev, О. V. Efimova |
| |
| Vol 15, No 4 (2022) |
Historical milestones of the invention and use of placebo |
Abstract
PDF (Rus)
|
|
A. N. Koterov |
| |
| Vol 15, No 3 (2022) |
Review of international practice of health care provider network planning |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, D. V. Lukyantseva, N. N. Sisigina |
| |
| 1 - 50 of 84 Items |
1 2 > >>
|
